Hemopurifier device in patients with solid tumours who have stable or progressive disease while on a treatment that includes pembrolizumab or nivolumab: protocol for an Australian safety, feasibility and dose-finding study
针对接受帕博利珠单抗或纳武利尤单抗治疗且病情稳定或进展的实体瘤患者，使用血液净化装置进行安全性、可行性和剂量探索研究的澳大利亚方案
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2025-102581
Brown, Michael P; Matos, Marco; Clarke, Stephen; Coates, P Toby; Pollock, Carol; Kurtkoti, Jagadeesh; Grau, Georges; Edinburg, Kelly; Bloesch, Alessio; de Necochea Campion, Rosalia; Khin, Nyan Y; Shin, John; LaRosa, Steven P
